-
Mar 25, 2011 03:13PM
Notable 52-Week Highs and Lows of the Day 03/25: (ORCL) (BMY) (ACN) High; (BBY) (MNOV) Low
-
Mar 15, 2011 11:10AM
Notable Analyst Rating Changes 03/15: (NFLX) (IPXL) (XOM) Upgraded; (CNQ) (CPB) (LLL) Downgraded
-
Feb 15, 2011 11:42AM
Mandel's Lone Pine Does Some Financial Swapping; Takes Platinum Over Gold; Exits Education (C)(JPM)(MA)(V)(EDU)
-
Sep 22, 2010 09:53AM
Daily State of the Markets 09/22: Blame It On The Bonds (Again)
-
Aug 12, 2010 09:36AM
Citi Maintains a 'Hold' on Computer Sciences (CSC); Looks for Back-Half Bounce in Results; We Remain Cautious
-
Jul 30, 2010 10:23AM
Citi Maintains a 'Buy' Rating on Cognizant Technology Solutions (CTSH); Will Modest Beat/Raise Be Enough?
-
Jun 25, 2010 09:19AM
Citi Maintains a 'Buy' on Accenture Ltd (ACN); Solid Quarter; Expect “Relief Rally” in Stock
-
Jun 17, 2010 09:14AM
Citi Maintains a 'Buy' on Accenture Ltd (ACN); Not Expecting Major Changes - Buy Headed into Earnings
-
Mar 23, 2010 10:25AM
Citi Maintains a 'Buy' Rating on Accenture Ltd (ACN), Lowers Estimates
-
Mar 19, 2010 10:37AM
Notable Analyst Rating Changes 03/19: BBY, TTEK, PGR, MAR, MCK Upgraded; PALM, FFIV, DTV, SPWRA, WFT, BPFH, HUM Downgraded
-
Dec 9, 2009 11:07AM
Notable Analyst Rating Changes for 12/9: S, MMM, CA, RNWK, NYX Upgraded; KR, ACN, LLL, LMT, RTN, MDAS Downgraded
-
Sep 28, 2009 10:19AM
Notable Analyst Rating Changes 9/28: CSCO, VPHM, ACN, AMAT, GD Upgraded; RBS, WFR, ISRG, WXS Downgraded
-
Sep 28, 2009 07:16AM
Citi Upgrades Accenture (ACN), Applied Materials (AMAT) to Buy; Downgrades MEMC (WFR) to Hold
-
Sep 3, 2009 10:21AM
Notable Analyst Rating Changes 9/3: BHI, BJS, APC, MVL, SI Upgraded; DE, HOV, BNI, INWK Downgraded
-
Jun 15, 2009 09:46AM
David Moenning's Daily State of the Markets: 6/15
-
Dec 4, 2008 09:42AM
David Moenning's Daily State of the Markets: 12/04
-
Apr 22, 2008 09:49AM
Notable Analyst Rating Changes 4/22: BRLC, NCC, MHS Upgraded; BEE, BJS, UNH, ACN Downgraded
-
Mar 28, 2008 09:24AM
Pre-Open Movers 3/28: JC Penney (JCP) Sinks on Lower Guidance, BioMimetic Therapeutics (BMTI) Higher After Addressing Concerns